Bayesian decision theoretic two-stage design in phase II clinical trials with survival endpoint.

Statistics in Medicine
Lili ZhaoScott M Schuetze

Abstract

In this paper, we consider two-stage designs with failure-time endpoints in single-arm phase II trials. We propose designs in which stopping rules are constructed by comparing the Bayes risk of stopping at stage I with the expected Bayes risk of continuing to stage II using both the observed data in stage I and the predicted survival data in stage II. Terminal decision rules are constructed by comparing the posterior expected loss of a rejection decision versus an acceptance decision. Simple threshold loss functions are applied to time-to-event data modeled either parametrically or nonparametrically, and the cost parameters in the loss structure are calibrated to obtain desired type I error and power. We ran simulation studies to evaluate design properties including types I and II errors, probability of early stopping, expected sample size, and expected trial duration and compared them with the Simon two-stage designs and a design, which is an extension of the Simon's designs with time-to-event endpoints. An example based on a recently conducted phase II sarcoma trial illustrates the method.

References

Mar 1, 1989·Controlled Clinical Trials·R Simon
Dec 15, 1994·Statistics in Medicine·H C Brunier, J Whitehead
Jan 3, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E L KornM C Christian
Apr 25, 2001·Biometrics·D A Follmann, P S Albert
Apr 17, 2003·BMC Medical Research Methodology·L Douglas Case, Timothy M Morgan
Sep 1, 2005·Statistics in Medicine·John M Lachin
Jan 21, 2006·Clinical Trials : Journal of the Society for Clinical Trials·Peter F ThallNizar M Tannir
Feb 18, 2006·Nature Reviews. Drug Discovery·Donald A Berry
Jul 18, 2006·Contemporary Clinical Trials·Andrew StoneAlan Barge
Mar 22, 2007·Journal of the National Cancer Institute·Katherine S PanageasDeborah Schrag
Jul 12, 2007·Journal of the National Cancer Institute·Robert Kane
Feb 21, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John K ChanDaniel S Kapp
Feb 20, 2009·Statistics in Medicine·Lili Zhao, George Woodworth
Sep 19, 2009·Computational Statistics & Data Analysis·Pulak Ghosh, Paul S Albert

❮ Previous
Next ❯

Citations

Jun 7, 2015·Statistical Methods in Medical Research·Siew Wan HeeNigel Stallard
Apr 5, 2019·Statistical Methods in Medical Research·Lili Zhao, Carl Koschmann
Jun 12, 2020·Pharmaceutical Statistics·Heng ZhouYing Yuan
Jan 1, 2014·Statistics in Biopharmaceutical Research·Jianrong Wu, Xiaoping Xiong
Jun 5, 2021·Pharmaceutical Statistics·Jianrong WuChia-Wei Hsu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.